-
A review article examining the potential adverse effects of energy drinks on kids generated a lot of buzz recently in the lay media. The beverage industry countered with information of its own, but the research referenced in the journal article lays out a solid foundation against the drinking of energy drinks, especially in children.
-
The patient asks, "Is it safe to take?" You pause, thinking, the FDA classifies it as a Category C, and everybody seems to use it, but how can anybody be sure? So, you finally respond, "It has been used a lot in pregnant patients and no harmful effects have been observed." But, you say to yourself, am I really confident? What would I do for myself or my spouse if in the same situation?
-
Lower plasma levels of b-amyloid 42/40 in elderly persons followed over 9 years were associated with greater cognitive decline, mainly in those with low measures of past education and literacy.
-
The fda has approved a new topical treatment for head lice infestation.
-
Elderly patients with depression respond favorably to bright light treatment.
-
Dietary fiber intake appears to lower all-cause mortality, including death from cardiovascular, infectious, and respiratory diseases.
-
Spironolactone may save the day with resistant hypertension.
-
-
These reports originally appeared in the February issue of Neurology Alert. At that time it was peer reviewed by M. Flint Beal, MD, Anne Parrish Titzel Professor, Department of Neurology and Neuroscience, Weill Cornell Medical Center, New York, NY. Dr. Beal reports no financial relationship to this field of study.
-
The fda has approved a new formulation of fentanyl for the management of breakthrough pain in cancer patients.
